India’s Global Impact: 11 Countries Recognize Indian Pharmacopoeia
Dr. Rajeev Raghuvanshi, the Drugs Controller General of India, announced that 11 countries have recognized the Indian pharmacopoeia as their standard. India supplies drugs, vaccines, and medical devices to over 200 countries. The country approves around 100 global clinical trials annually, showcasing its robust regulatory system.
India’s National Regulatory Authority (NRA) is advancing with the approval of cutting-edge technologies like CAR T-cell therapy and mRNA vaccines. Recently, six countries were notified for product approval in India.
In October, the Ministry of Health and Family Welfare confirmed that India’s vaccine regulatory system meets WHO standards. An expert team from WHO conducted a review from September 16 to 20, affirming India’s compliance with international vaccine regulations.
India, a major vaccine producer with 36 manufacturing facilities, supplies vaccines to 150 countries, solidifying its role as a global vaccine supplier.
Doubts Revealed
Pharmacopoeia -: A pharmacopoeia is a book or official publication that lists medicines and their standards. It helps ensure that medicines are safe and effective for people to use.
Drugs Controller General -: The Drugs Controller General of India is a person who makes sure that medicines and medical products in India are safe and work well. They are like a boss for medicine safety in the country.
CAR T-cell therapy -: CAR T-cell therapy is a new and advanced treatment for some types of cancer. It uses special cells from the patient’s own body to fight cancer cells.
WHO -: WHO stands for the World Health Organization. It is a global group that works to make sure people all over the world are healthy and safe from diseases.
Vaccine regulatory system -: A vaccine regulatory system is a set of rules and checks to make sure vaccines are safe and effective before people use them. It helps protect people from getting sick from diseases.